Worksport Ltd — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Worksport Ltd filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.10M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $8.48M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.53M | Mar 27, 2025 |
| FY2012 | Sep 30, 2012 | $0 | Mar 26, 2013 |
| FY2012 | Sep 30, 2011 | $0 | Mar 26, 2013 |
| FY2011 | Sep 30, 2010 | $0 | Dec 20, 2011 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.10M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $8.48M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.53M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $116.5K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $303.8K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $346.1K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.93M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $481.5K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $408.7K | May 13, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $408.7K | Jun 15, 2018 |
| FY2017 | Dec 31, 2016 | $361.1K | Jun 15, 2018 |
| FY2016 | Dec 31, 2015 | $651.7K | Sep 18, 2017 |
| FY2015 | Dec 31, 2014 | $593.0K | May 9, 2016 |
| FY2014 | Dec 31, 2013 | $465.8K | Apr 13, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.47M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $905.7K | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $240.5K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $59.5K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($47.0K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $47.1K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $238.5K | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $96.6K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $176.9K | May 13, 2019 |
| FY2017 | Dec 31, 2016 | $27.1K | Jun 15, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($16.16M) | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | ($14.93M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($12.53M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($7.90M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($1.19M) | Mar 31, 2022 |
| FY2020 | Mar 31, 2020 | ($152.3K) | Apr 13, 2021 |
| FY2020 | Dec 31, 2019 | ($359.0K) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($1.76M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($3.40M) | May 13, 2019 |
| FY2017 | Dec 31, 2016 | ($1.14M) | Jun 15, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($18.81M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($15.47M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($14.74M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($12.77M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($7.56M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($986.2K) | Mar 31, 2022 |
| FY2020 | Mar 31, 2020 | ($124.5K) | Apr 13, 2021 |
| FY2020 | Dec 31, 2019 | ($537.9K) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($1.21M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($1.78M) | May 13, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.29M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.67M | Mar 27, 2025 |
| FY2015 | Dec 31, 2015 | $47.3K | May 9, 2016 |
| FY2015 | Dec 31, 2014 | $4.9K | May 9, 2016 |
| FY2014 | Dec 31, 2013 | $659 | Apr 13, 2015 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.45M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $14.62M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $13.87M | Mar 27, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($17.31M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($10.14M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($11.93M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($7.98M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($4.21M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($695.1K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($2.2K) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($379.3K) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($194.9K) | May 13, 2019 |
| FY2017 | Dec 31, 2016 | ($237.0K) | Jun 15, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $789.5K | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $528.2K | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.69M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $11.05M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.10M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $8.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $98.4K | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $1.9K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $4.9K | May 13, 2019 |
| FY2017 | Dec 31, 2016 | $551 | Jun 15, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.71M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $25.74M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $25.95M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $32.76M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $36.29M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.90M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $481.3K | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $557.4K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $905.5K | May 13, 2019 |
| FY2017 | Dec 31, 2016 | $336.7K | Jun 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.84M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $8.32M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $7.78M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $8.65M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.11M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.73M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.36M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $780.9K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $533.9K | May 13, 2019 |
| FY2017 | Dec 31, 2016 | $1.34M | Jun 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.88M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $17.41M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $18.18M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $24.12M | Mar 27, 2025 |
| FY2023 | Dec 31, 2021 | $34.18M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $169.5K | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | ($882.6K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | ($223.6K) | Apr 13, 2021 |
| FY2019 | Dec 31, 2017 | $371.5K | May 14, 2020 |
| FY2018 | Dec 31, 2016 | ($1.00M) | May 13, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($83.87M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($64.48M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($48.31M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($33.38M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($20.85M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($12.87M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($11.68M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($10.35M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($8.59M) | May 13, 2019 |
| FY2017 | Dec 31, 2016 | ($5.19M) | Jun 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.95M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.88M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.37M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $14.62M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $28.57M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.11M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $12.0K | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $25.3K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $67.0K | May 13, 2019 |
| FY2017 | Dec 31, 2015 | $14.5K | Jun 15, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.68M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $5.26M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $5.30M | Mar 27, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | (8) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | (8) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9.81M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | 4.02M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | 2.03M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 17.16M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 16.95M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 3.82M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 41.91M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | 24.63M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | 20.39M | May 13, 2019 |
| FY2017 | Dec 31, 2016 | 68.09M | Jun 15, 2018 |